In the face of so much bad news, here in Brazil we are finally starting to see interesting results in the fight against the new coronavirus, which has changed the structure of all powers around the world.
This week, Brazilian scientists from São Paulo will test, on 500 patients, a drug, with almost no side effects, with 94% efficacy in cells infected by the new coronavirus, with results, at most, in a month.
The Minister of Science, Technology, Innovations and Communications, Marcos Pontes, released the information in an official statement, but we need to remain calm!
According to data provided by Pontes, the country is also developing artificial intelligence equipment to test people suspected of having Continues after the publication
Scientists said the response is within a minute and the test uses domestic reagents.
Vaccines take longer than drug repositioning, but we are working on a double vaccine, for both Influenza and the new coronavirus. He also stressed that only science has the power to fight the virus.
Possible cure for Coronavirus coming from Brazil
With scientific caution, he did not disclose the name of the medicine so as to “avoid a desperate rush to buy it. This is because it is a well-known drug, widely available on the market.” This is according to information from the Secretary of Policies for Training and Strategic Actions of the Ministry of Science, Technology, Innovations and Communications (MCTIC), Marcelo Morales.
Another piece of good news, as the minister said, is that Brazil will have a treatment solution in its hands by mid-May at the latest, with medicine available even in pediatric formulation.”
With the approval of the federal government, the medicine will be tested on 500 patients in seven hospitals, five in Rio de Janeiro, one in São Paulo and another in Brasília.
Important considerations about our possible cure.
Another important detail: the drug will be administered daily for five days, with a further nine days of observation. In total: in up to 14 days, we will be able to see whether the effects on patients will be the same as those already proven in infected cells”, highlighted the minister.
But we must remain calm, the clinical trial will be carried out with patients who are hospitalized to monitor symptoms and viral load.
Pontes also clarified that the protocol will be a completely randomized administration, that is, neither doctors nor patients will know who is taking the medication and who is receiving placebos.
Anyway, we're waiting, right? For more information, stay tuned to our news secure digital portal.
Source: Secretary of Sao Paulo